![Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection | Science Advances Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection | Science Advances](https://www.science.org/cms/10.1126/sciadv.abj1281/asset/d5760a07-a29b-4e51-a409-7413c5e44de6/assets/images/large/sciadv.abj1281-f1.jpg)
Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection | Science Advances
![Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings | ACS Synthetic Biology Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings | ACS Synthetic Biology](https://pubs.acs.org/cms/10.1021/acssynbio.0c00359/asset/images/large/sb0c00359_0013.jpeg)
Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings | ACS Synthetic Biology
![Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction | Scientific Reports Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-81487-y/MediaObjects/41598_2021_81487_Fig1_HTML.png)
Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction | Scientific Reports
![Jam-packed, 55-and-older event day before Gov. Abbott COVID-19 diagnosis had no masks, little distancing | KXAN Austin Jam-packed, 55-and-older event day before Gov. Abbott COVID-19 diagnosis had no masks, little distancing | KXAN Austin](https://www.kxan.com/wp-content/uploads/sites/40/2021/08/Gov-Mask.png)
Jam-packed, 55-and-older event day before Gov. Abbott COVID-19 diagnosis had no masks, little distancing | KXAN Austin
![Clinical validation of colorimetric RT-LAMP, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern | medRxiv Clinical validation of colorimetric RT-LAMP, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/06/02/2021.05.26.21257488/F1.large.jpg)
Clinical validation of colorimetric RT-LAMP, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern | medRxiv
![Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa - eClinicalMedicine Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa - eClinicalMedicine](https://www.thelancet.com/cms/attachment/f52104c0-b251-45a0-9513-69f189106063/gr1_lrg.jpg)
Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa - eClinicalMedicine
Virus-Like Particles as Positive Controls for COVID-19 RT-LAMP Diagnostic Assays | Biomacromolecules
![Rapid SARS-CoV-2 testing: LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic | Clinical OMICs Rapid SARS-CoV-2 testing: LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic | Clinical OMICs](https://www.liebertpub.com/cms/10.1089/clinomi.08.01.18/asset/images/medium/clinomi.08.01.18.t001.png)
Rapid SARS-CoV-2 testing: LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic | Clinical OMICs
![Abbott on Twitter: "“By the end of this year, we will have shipped globally over 300 million COVID tests across all of our different platforms.” – Robert Ford, our President and CEO, Abbott on Twitter: "“By the end of this year, we will have shipped globally over 300 million COVID tests across all of our different platforms.” – Robert Ford, our President and CEO,](https://pbs.twimg.com/media/EoZ_8VWXUAMnQTu.jpg)
Abbott on Twitter: "“By the end of this year, we will have shipped globally over 300 million COVID tests across all of our different platforms.” – Robert Ford, our President and CEO,
![LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding | Nature Biotechnology LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding | Nature Biotechnology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41587-021-00966-9/MediaObjects/41587_2021_966_Fig1_HTML.png)
LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding | Nature Biotechnology
![Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform - Dec 16, 2020 Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform - Dec 16, 2020](https://mma.prnewswire.com/media/1387357/Abbott_BinaxNOWHometest_1918_TW_1200x675.jpg?p=twitter)